The fact that a plasma factor was responsible for the stimulation of r
ed cell production has been known for more than 35 years. However, it
is only recently that the gene responsible for its production and its
molecular structure has been identified. Furthermore, recombinant huma
n erythropoietin is now available for clinical use. This article detai
ls the molecular biology and clinical pharmacology of this remarkable
growth factor.